News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PRANA Biotechnology (PRAN) Announces PNAS Publication Describing New Class of Anti-Amyloid Drugs



5/13/2008 11:33:31 AM

MELBOURNE, AUSTRALIA--(Marketwire - May 13, 2008) - Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced a publication in the Proceedings of the National Academy of Sciences (PNAS) journal,(1) describing a completely new class of amyloid inhibiting drugs.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES